SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001104659-21-117940
Filing Date
2021-09-21
Accepted
2021-09-21 17:07:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A tm2125174d4_sctoia.htm SC TO-I/A 21544
  Complete submission text file 0001104659-21-117940.txt   23307
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filed by) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-87033 | Film No.: 211267121
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences